New research highlights postnatal regeneration limits and pathological remodeling of the cardiac conduction system after myocardial infarction, uncovering mechanisms behind clinical arrhythmogenesis ...

When patients with congenital heart issues have an operation, surgeons have to proceed with an "eye of faith" as they work around conduction tissue—a network of cells and electrical signals that ...

Discordant results from two trials comparing conduction system pacing with biventricular pacing for cardiac resynchronization therapy (CRT) leave open the question of whether conduction system pacing ...

NEW ORLEANS -- Among patients with heart failure, conduction system pacing-guided cardiac resynchronization therapy was associated with improvements in left ventricular ejection fraction (LVEF) ...

Medtronic got an FDA approval for its OmniaSecure defibrillation lead, opening up its use in the heart’s left bundle branch, while Biotronik touted the commercial rollout of its Solia CSP S lead.

Please provide your email address to receive an email when new articles are posted on . Medtronic announced its cardiac lead received an expanded indication from the FDA for left bundle branch area ...

Heart conduction disorders can often lead to serious or fatal complications including complete heart block or heart failure. Left ventricular conduction disease occurs when there is an electrical ...

Patients with atrioventricular (AV) block who don’t have an indication for cardiac resynchronization therapy (CRT) do better when treated with conduction-system pacing versus right ventricular septal ...